Furthermore, spike protein–specific CD8+ T cell frequencies may have been reduced because samples were analyzed at day 28 after vaccination, which is 2 weeks past the peak time point of the T cell responses (13), although they were still comparable to CD8+ T cell responses from convalescent patients with COVID-19. The gene discussed is CD8A; the disease is COVID-19.